Denali Therapeutics Inc. (DNLI) NASDAQ
19.11
-0.2685(-1.39%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.9B |
| Enterprise Value | 2.73B |
| P/E Ratio | -6.63 |
| PEG Ratio | 3.22 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.35 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -5.47 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.45 |
| Return On Equity | -0.5 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -11.18M |
| EBITDA | -497.63M |
| Net Income | -512.54M |
| Diluted EPS | -2.97 |
Balance Sheet
| Total Cash | 867.88M |
| Total Cash/Share | 4.95 |
| Total Debt | 42.29M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 9.16 |
| Book Value Per Share | 5.78 |
Price History
| 52-Week Change | 67.07 |
| 52-Week High | 23.77 |
| 52-Week Low | 10.8 |
| Moving Average 50 Days | 20.49 |
| Moving Average 200 Days | 16.93 |
Statistics
| Average Volume | 1.8M |
| Shares Outstanding | 158.59M |
| % Held by Institutions | 87.66 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
